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We report a rare case of hepatocellular carcinoma in native liver in a case of biliary atresia. The patient
was a 38-year-old female with three children who had an aggressive tumor, resulting in her subsequent
death. We also review 14 reports, published previously in the English language medical literature,
concerning hepatocellular carcinoma originating from native liver in biliary atresia cases and discuss the
possible etiology, and propose more careful follow up for the patients with biliary atresia who suffer from
repetitive cholangitis and/or experience the child delivery.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Hepatocellular carcinoma (HCC) is rarely seen in cirrhotic liver of
biliary atresia, with only 20 cases having been reported in the En-
glish language medical literature [1e14]. Almost all hepatocellular
carcinomas seen in biliary atresia are slow growing and not very
aggressive tumors, with half of them incidentally found in extracted
livers at autopsy or after liver transplantation.
Here we report on a 38-year-old female patient with biliary
atresia, who had long suffered from repetitive cholangitis and
ﬁnally died of a hepatocellular carcinoma in her native liver.1. Case
A 38-year-old female patient was referred to our department
because an hepatic tumor was suspected after a high serum alpha-
fetoprotein (AFP) level, and as subsequently demonstrated by
abdominal computed tomography (CT) scan. She had previously
been admitted to our institute because of prolonged jaundice
during her early infantile years. As a 71-days-old baby, afteru, Tokyo 157-8535, Japan.
ori).
Inc. This is an open access article useveral examinations, the patient was diagnosed with biliary
atresia type III and underwent portoenterostomy with a bile
drainage stoma. After the operation, her jaundice subsided and
since then, she has been followed at our outpatient clinic. Periodic
blood tests showed mild liver dysfunction and she underwent
splenectomy at 24 years of age because of worsening hyper-
splenism caused by prolonged portal hypertension. The patient
had borne three children, delivering them at 30, 35, and 38 years
of age. She was followed at our outpatient clinic every three
months and at 38 years of age abdominal ultrasound were taken
and a hepatic mass, 3 cm in diameter, was found in the posterior
segment of the right lobe (Fig. 1a) which was ﬁrst thought to be
focal nodular hyperplasia. But a blood test showed a high AFP level
(2632.8 ng/mL). The mass grew rapidly to 6 cm by two weeks
which was ascertained by abdominal CT scans, and hepatocellular
carcinoma was strongly suspected (Fig. 1b and c). Serological tests
were negative for hepatitis B antigen and hepatitis C antibody. A
month later, a laparotomy revealed a bloody ascites in the
abdominal cavity, which suggested a spontaneous rupture of the
tumor. The posterior segment of the right lobe (Fig. 2a) was
resected and the tumor was macroscopically removed. The path-
ological diagnosis was a moderately differentiated hepatocellular
carcinoma (Fig. 2b and c); background liver tissue showed severender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 2. (a) Intraoperative photo of the tumor. The tumor had ruptured and was sited in the posterior segment of the right liver. Segment 1 (caudate lobe) was very hypertrophic. (b)
Macroscopic appearance of the tumor, which was well encapsulated, but partially necrotic and ruptured. (c) Microscopic ﬁndings revealed that the tumor was a moderately
differentiated, hepatocellular carcinoma.
Fig. 3. (a) Tumor recurrence was detected in the caudate lobe of the liver, which was found to be extremely hypertrophic, three months after the ﬁrst operation. The tumor was
resected in a second operation. The arrow indicates the middle hepatic vein. (b) The tumor recurred after a second operation. Its growth could not be controlled by chemotherapy
combined with Sorafenib.
Fig. 1. (a) An abdominal ultrasound examination demonstrated a mass of 3.0 cm diameter in the right lobe of the liver. (b) Two weeks later, an abdominal CT scan showed the mass
in the liver had grown rapidly to a diameter of 6.0 cm. Arterial phase imaging revealed the mass to have an enhanced margin. (c) An abdominal CT of the venous phase showed a
relatively contrasting mass with low density. These results strongly suggested the mass was a hepatocellular carcinoma.
Y. Kanamori et al. / J Ped Surg Case Reports 3 (2015) 501e504502
Table 1
Hepatocellular carcinoma in native liver of biliary atresia.
Case Gender Age AFP HBsAg/HCVAb Diagnosis Tx Status References
1 M 3y NA NA Incidental None Dead (autopsy) [1]
2 F 5m NA NA Incidental None Dead (autopsy) [2]
3 M 2y NA NA Incidental None Dead (autopsy) [3]
4 F 6y NA NA Incidental None Dead (autopsy) [4]
5 F 12y þ NA Liver mass LTx Alive [5]
6 F 4y þ NA Incidental LTx Alive [5]
7 F 6y þ / Liver mass Ethanol injection Dead [7]
8 ? 12y þ NA Liver mass LTx Alive [8]
9 M 8y þ NA Liver mass LTx Alive [9]
10 F 10y  NA Liver mass LTx Alive [9]
11 F 11y NA NA Incidental LTx Alive [6]
12 M 4y  NA Liver mass LTx Alive [13]
13 F 2y þ NA Incidental LTx Alive [13]
14 F 1y þ NA Liver mass LTx Alive [13]
15 F 17y  NA Liver mass LTx Alive [13]
16 M 1y  NA Incidental LTx Alive [13]
17 M 10m þ / Incidental LTx Alive [12]
18 M 19y  NA Liver mass LTx Alive [11]
19 M 8m þ NA Liver mass LTx Alive [10]
20 F 10m NA NA Incidental LTx Alive [14]
21 F 38y þ / Liver mass Tumor resection Dead Our case
Tx: treatment for the tumor, HBsAg: hepatitis B antigen, HCVAb: hepatitis C antibody, NA: not available, LTx: liver transplantation.
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rence of the tumor was detected in hypertrophic segment 1, which
was subsequently resected again (Fig. 3a). After the second oper-
ation, the persistence of a high fever was noted, together with
multiple lung metastases as demonstrated by lung CT scans; tumor
recurrence was also demonstrated in the residual liver. Sorafenib
was administered but tumor progression could not be controlled
(Fig. 3b), and a year after the ﬁrst operation, the patient died after
tumor rupture and hepatic failure.2. Discussion
Hepatocellular carcinoma is relatively rare in childhood and is
often seen in cirrhotic liver with chronic viral hepatitis. Conversely,
HCC is rarely seen in liver with biliary atresia, with only 20 cases
previously reported in the English language medical literature
[1e14] (Table 1). Our case is the twenty-ﬁrst case to be reported.
Brieﬂy in summary, ﬁve out of the 20 HCC in biliary atresia cases
had been autopsied [1e4,7], and reported in the days prior to the
liver transplantation era. Of the 20 cases, eight were male and 11
were female, with one of unknown sex, and all were under the age
of 20. AFP was elevated in 10 out of 15 cases, including our reported
case [5,7,9,10,12,13]. Given the data on chronic viral infection, such
as hepatitis B or hepatitis C, is quite restrictive, only three cases
were checked for infection, including our case, and all were found
to be negative [7,11]. Liver transplantation was successfully per-
formed in 15 cases. In 10 cases, including autopsied cases, HCC was
incidentally found in the liver.
Our case is strikingly uncharacteristic for HCC in bilary atresia in
some respects: For instance, tumor growth was very rapid and
aggressive, which was quite different from that of previously re-
ported cases. The patient was followed every three months with
blood tests and the tumor was found in its early stages, but was too
aggressive to prevent death. Additionally, the patient’s age (38
years) made her the oldest among the reported cases. The patient
had a cirrhotic liver for a long time; this is a well-known risk factor
for HCC, but in biliary atresia, HCC is rarely a complication. More-
over, the patient had suffered from repetitive cholangitis for a long
time, suggesting that chronic inﬂammation might have triggered
the observed tumorigenesis. The patient had also experienced childbirth three times, suggesting hormonal changes may have caused
an imbalance of homeostasis in liver metabolism, which might also
be related to the etiology of HCC tumorigenesis [15].
Considering her medical history, we should respond more
rapidly for the tumor resection in this case, otherwise the only
chance of saving the patient was liver transplantation. But tumor
progression was very rapid in this patient, which did not allow for
the selection of an appropriate donor in time for a living related
liver transplantation.3. Conclusion
A 38-year-old patient with biliary atresis could not be saved
because of an extremely aggressive HCC, in spite of periodic follow-
up. Recently, the number of long-term survivors of biliary atresia in
native liver has increased. However, the establishment of follow-up
schedules in these patients are lacking. Our case is a valuable lesson
for considering such a scheme in future. We now recommend more
careful follow up for the patients with biliary atresia who suffer
from repetitive cholangitis and/or experience the child delivery. To
be more concrete, periodic AFP measurement and ultrasound ex-
amination are important and once AFP elevation appears the early
abdominal CT or MRI be recommended.References
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